WEST PHARMACEUTICAL SVSC INC's ticker is and the CUSIP is 955306955. A total of 2 filers reported holding WEST PHARMACEUTICAL SVSC INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787 | +194.8% | 2,100 | +200.0% | 0.00% | – |
| Q2 2023 | $267 | -35.7% | 700 | -41.7% | 0.00% | – |
| Q1 2023 | $415 | -79.2% | 1,200 | -85.9% | 0.00% | -100.0% |
| Q4 2022 | $2,000 | -99.7% | 8,500 | +240.0% | 0.00% | +100.0% |
| Q3 2022 | $615,000 | +583.3% | 2,500 | +733.3% | 0.00% | – |
| Q2 2022 | $90,000 | -97.8% | 300 | -96.9% | 0.00% | -100.0% |
| Q1 2022 | $4,024,000 | -42.0% | 9,800 | -33.8% | 0.00% | -42.9% |
| Q4 2021 | $6,941,000 | +366.5% | 14,800 | +261.0% | 0.01% | +600.0% |
| Q3 2021 | $1,488,000 | +1.1% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,472,000 | +5157.1% | 4,100 | +409900.0% | 0.00% | – |
| Q1 2021 | $28,000 | – | 1 | -66.7% | 0.00% | – |
| Q4 2020 | $0 | – | 3 | -85.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 21 | +2000.0% | 0.00% | – |
| Q1 2020 | $15,000 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $15,000 | -98.5% | 1 | -98.6% | 0.00% | -100.0% |
| Q3 2019 | $1,021,000 | -27.8% | 72 | -36.3% | 0.00% | -25.0% |
| Q2 2019 | $1,414,000 | -31.0% | 113 | -39.2% | 0.00% | -33.3% |
| Q1 2019 | $2,049,000 | -19.9% | 186 | -28.7% | 0.01% | -25.0% |
| Q4 2018 | $2,558,000 | +127800.0% | 261 | +2510.0% | 0.01% | – |
| Q1 2017 | $2,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 3 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |